Form 4: Director Matthew Morris Executes Privia Health Stock Sale

Director Matthew Morris exercised stock options and sold 18,113 shares of Privia Health Group, Inc. under a 10b5-1 plan.

Summary

• Director Matthew Morris exercised options to acquire 18,113 shares of common stock at an exercise price of $2.00 per share.
• The reporting person subsequently sold the acquired shares in two tranches on May 1, 2026, and May 4, 2026.
• The sales were executed at weighted average prices of $24.99 and $24.96 per share, respectively.
• All transactions were conducted pursuant to a pre-established Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were conducted under a pre-arranged 10b5-1 plan and represent routine portfolio management by an insider.

Positives

• The transactions were executed under a pre-planned Rule 10b5-1 trading plan, which typically indicates a non-discretionary approach to liquidity rather than a reaction to non-public information.

Negatives

• The director reduced his direct beneficial ownership of common stock by exercising and selling the shares, though he retains a significant remaining position.

Risks

• Future share price volatility could impact the value of the director's remaining 3,674,201 unexercised stock options.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to avoid potential conflicts of interest or accusations of insider trading.

Stakeholder Impact

• Minimal impact on shareholders as the sales were pre-planned and represent a small fraction of the director's total holdings.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Privia Health Group, PRVA, Insider Trading, Form 4, Stock Options, Rule 10b5-1